A re-focused and re-energised National Drugs Strategy, Issue 14, Summer 2005

The Mid-Term Review1 of the National Drugs Strategy 2001–2008, published on 2 June 2005, recommends a number of additions and amendments to the existing Strategy, including making rehabilitation a new, ‘fifth’ pillar of the Strategy. The Steering Group that oversaw the Review, and the extensive consultation process on which it is based, found that the aims and objectives of the Strategy are fundamentally sound. While what has been achieved varies from action to action, progress has been made across the four pillars of supply reduction, prevention, treatment and research, and in the co-ordination of the institutional structures of the Strategy. The Review recommends the addition of eight new actions, the replacement of nine of the existing actions and amendments to a further eight. It also recommends revisions to the Strategy’s key performance indicators, reflecting new developments and data availability. The recommendations serve to ‘re-focus and re-energise’ the Strategy in the remaining period up to 2008.This resource was contributed by The National Documentation Centre on Drug Use.

An Introduction to Health Economics & Economic Evaluations

- Overview of Economic Evaluation - Stages in Economic Evaluation  

Introduction to Basic Health Care Statistics

A video summary by Catherine Comiskey

Introduction to Evaluation and Health Economics

A video summary by Orla Doyle

Introduction

(Résumé de l'ouvrage) L'apôtre Paul est au centre d'une intense interrogation aujourd'hui. Quel fut son rapport au judaïsme ? Que sait-il de Jésus ? Comment s'est construite sa théologie, d'une épître à l'autre ? Dix-huit biblistes suisses, français, italiens, allemands et américains ont été invités à explorer la question. Leurs analyses sont précises, rigoureuses et documentées. On trouvera ici une synthèse unique en français des plus récentes avancées de la recherche paulinienne.